Date(s) - 18 Nov 2019
3:00 pm - 6:00 pm
Summary: Life changing therapies derive from innovative life science R&D, with bio-pharmaceutical scientists tackling increasing science and technology challenges. Big, complex challenges need bold actions, and the most effective solutions often require collaboration. Is your company actively collaborating with other organizations so overcome innovation barriers. Should your company be more collaborative?
Please join us for an informative session addressing the value and importance of pre-competitive collaboration in life sciences. This event features experienced speakers and an opportunity to explore the possibilities – followed by a networking reception.
3:15 Opening remarks – John Hallinan, MassBio CBO
3:20 Plenary speaker- Liz Leveille, Merck, Assoc VP and Head, Boston Innovation Hub
3:40 Panel Discussion, Tom Plasterer (AZ), Dana Vanderwall (BMS), Joe Donahue (Accenture), Chris Waller (EPAM) – Moderator. Additional panelists tbd
4:25 Plenary speaker – Mark Borowsky, NIBR, Head of Informatics Systems and Scientific Data Analysis
Networking reception, drinks and appetizers
Your online registration is needed to provide an accurate count for the food and drink order.